II
AMRX icon

Inspire Investing’s Amneal Pharmaceuticals AMRX Stock Holding History

Inspire Investing’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,748
Closed -$229K – 799
2021
Q2 		$229K Buy
44,748
+1,356
+3% +$7.71K 0.03% 573
2021
Q1 		$292K Sell
43,392
-2,922
-6% -$16.2K 0.04% 530
2020
Q4 		$212K Buy
46,314
+15,750
+52% +$69.8K 0.05% 600
2020
Q3 		$119K Sell
30,564
-10,294
-25% -$44K 0.03% 422
2020
Q2 		$194K Sell
40,858
-17,664
-30% -$72.7K 0.07% 465
2020
Q1 		$204K Buy
+58,522
New +$248K 0.08% 420

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inspire Investing's AMRX Position: Q3 2021 in Review

Inspire Investing sold out of Amneal Pharmaceuticals (AMRX) in Q3 2021, closing a stake of 44,748 shares — an estimated $229K sold.

Inspire Investing first reported a position in AMRX in Q1 2020 and held it in 6 quarters. The position peaked at $292K in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2021.

  • Inspire Investing reported no remaining Amneal Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Inspire Investing sold 44,748 Amneal Pharmaceuticals shares in Q3 2021, an estimated $229K.
  • Inspire Investing first reported a position in Amneal Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Inspire Investing's Amneal Pharmaceuticals position peaked at $292K in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2021.

Based on Inspire Investing's 13F filing for Q3 2021, filed 9 Nov 2021.